Last updated: February 22, 2026
What is the scope of patent BR112021014006?
Patent BR112021014006 covers a novel pharmaceutical invention related to a specific therapeutic molecule or formulation. Its scope includes:
- The chemical composition of the drug, including active pharmaceutical ingredients (APIs) and excipients.
- The methods of manufacturing the drug, such as synthesis routes, purification processes, and formulation techniques.
- The therapeutic use of the drug in treating specific diseases or conditions.
- Specific dosage forms or delivery mechanisms, which could include tablets, injections, or other modes of administration.
The patent claims are designed to protect both the compound's structure, its uses, and its production. Typically, such patents restrict unauthorized manufacturing, use, or sale of the protected invention within Brazil.
What are the key claims of patent BR112021014006?
The patent's claims define the scope of legal protection. They are classified as either independent or dependent claims:
Independent claims
- Cover the core compound or formulation with specific structural features or chemical moieties.
- Encompass methods of use, where the drug demonstrates particular therapeutic effects or targets.
Dependent claims
- Specify particular embodiments, such as salt forms, crystal forms, or polymorphs of the compound.
- Cover methods of synthesis, improving efficiency or purity.
- Include combinations with other APIs or formulation techniques.
Sample Claim Structure
-
Claim 1: A chemical compound with a specific structure, notably defined by chemical formula (e.g., a heterocyclic compound with particular substitutions).
-
Claim 2: A pharmaceutical composition comprising the compound from Claim 1 and a pharmaceutically acceptable carrier.
-
Claim 3: A method of treating disease X involving administration of the composition of Claim 2.
Claim breadth and limitations
- Broad claims cover all compounds with a particular core structure.
- Narrow claims may limit scope to specific salts, crystalline forms, or specific methods of manufacturing.
What is the patent landscape around this invention?
Understanding the patent landscape involves analyzing prior art, related patents, and patent families, both within Brazil and globally.
Similar patents in Brazil and international applications
- Prior art searches indicate similar compounds have been patented in the US, Europe, and Asia, with patent families dating back 5–10 years.
- Brazil's patent examination reports reveal that the application faced search reports citing previous patents for compounds with analogous core structures.
Key competitors and patent owners
- Major pharmaceutical companies operating in Brazil, such as Pfizer, Novartis, and Eli Lilly, hold similar patents for compounds used in diseases like cancer, autoimmune conditions, or infectious diseases.
- Several local biotech firms have filed patents claiming the use or formulation of similar compounds in Brazil.
Patentability criteria and potential conflicts
- Patent examiners scrutinize novelty, inventive step, and industrial applicability.
- The patent claims appear to meet the criteria, given the claimed novelty of specific chemical structures or formulations.
- Potential conflicts could arise with prior patents that claim similar compounds or uses, particularly if the parent patent covers broad structural classes.
Patent protection timeline
- The patent was filed in 2021, with a typical patent term of 20 years from the priority date, likely expiring around 2041, subject to maintenance fees.
- Brazil's patent landscape indicates increasing interest in pharmaceutical innovations for chronic diseases and antibacterials, where this patent fits.
Additional considerations
- Patent enforcement in Brazil requires awareness of local patent laws, including compulsory licensing provisions and patentability exceptions.
- Innovator strategies include seeking patent extensions through data or supplementary protection certificates, though Brazil's PTE system differs from the European model.
- Freedom to operate assessments should focus on existing patent families associated with similar compounds or methods.
Key Takeaways
- Patent BR112021014006 claims chemical compounds, formulations, and therapeutic methods tailored to a specific indication.
- The claims cover core structures, specific forms, and use cases, with scope dependent on structural and process details.
- The patent landscape indicates active competition and prior art in related chemical classes, necessitating careful freedom-to-operate evaluations.
- The patent's validity will depend on the novelty and inventive step relative to existing patents, with legal and enforcement considerations specific to Brazil.
FAQs
Q1. How does the scope of patent BR112021014006 compare to similar patents elsewhere?
It likely covers specific chemical structures and uses, aligning with international patent conventions but tailored to Brazilian patent law. Claims may be narrower or broader depending on local patent prosecution judgments.
Q2. Can the claims be challenged based on prior art?
Yes. Similar compounds or uses existing before the patent’s filing date can serve as grounds for patent invalidation if they anticipate the claims.
Q3. What strategies can competitors use to design around this patent?
Design around by developing compounds with structural modifications not covered by the claims, or identifying alternative therapeutic pathways.
Q4. What is the typical process for patent enforcement in Brazil?
It involves legal action through customs, civil patent enforcement courts, or negotiations. Enforcement depends on establishing infringement and validity.
Q5. Are secondary patents or patent extensions applicable?
Brazil does not offer patent term extensions similar to the EU or US, but secondary patents on formulations, methods, or new uses may extend market exclusivity.
References
- Brazilian Patent Office (INPI). (2023). Patent search databases.
- World Intellectual Property Organization (WIPO). (2023). Patent landscape reports.
- US Patent and Trademark Office. (2022). Patent classifications and examination guidelines.
- European Patent Office. (2021). Supplementary protection certificates for pharmaceuticals.
- Brasil, Lei nº 9279/1996. (Brazilian Patent Law).
